People: Adamas Pharmaceuticals Inc (ADMS.OQ)
20 Sep 2019
Mr. Alfred G. Merriweather is no longer as Chief Financial Officer of the company. Effective October 31, 2019. Mr. Merriweather has held executive leadership roles at numerous companies in the life sciences industry throughout his career. Before coming to Adamas, he was Chief Financial Officer at RainDance Technologies, Inc., a life science tools company, from November 2013 to February 2017, where he was responsible for the finance, information technology, human resources and general legal functions. Prior to RainDance, he served as Chief Financial Officer of Verinata Health, Inc., a prenatal laboratory testing company, from January 2012 to July 2013, where he was responsible for the finance and general legal functions, and as Senior Vice President and Chief Financial Officer of Celera Corporation, a diagnostic products and laboratory testing company, from December 2010 until May 2011, where he was responsible for the finance and information technology functions. Mr. Merriweather has spent over 25 years in senior financial positions at several private and public life science companies, including Monogram Biosciences, Inc. and Laserscope. Mr. Merriweather received a Bachelor’s degree from the University of Cambridge in the United Kingdom.
|Total Annual Compensation, USD||600,600|
|Restricted Stock Award, USD||214,903|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||821,547|
|Fiscal Year Total, USD||1,637,050|